HLA-CandKIRcombined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HLA-CandKIRcombined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume 23, Issue 8, Pages 652-659
Publisher
Wiley
Online
2016-03-06
DOI
10.1111/jvh.12525
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic variants in five novel loci includingCFBandCD40predispose to chronic hepatitis B
- (2015) De-Ke Jiang et al. HEPATOLOGY
- Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir
- (2015) Femke Stelma et al. JOURNAL OF INFECTIOUS DISEASES
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levels
- (2014) Louis Jansen et al. JOURNAL OF HEPATOLOGY
- Human leukocyte antigen (HLA)-C polymorphisms are associated with a decreased risk of rheumatoid arthritis
- (2014) Yiqun Zhang et al. MOLECULAR BIOLOGY REPORTS
- Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitits B patients treated with peg-interferon and adefovir
- (2013) Annikki de Niet et al. ANTIVIRAL THERAPY
- Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with peginterferon alfa-2a and adefovir
- (2013) R Bart Takkenberg et al. ANTIVIRAL THERAPY
- Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels
- (2013) Milan J. Sonneveld et al. HEPATOLOGY
- Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype
- (2013) Maurizia R. Brunetto et al. JOURNAL OF HEPATOLOGY
- Large Spectrum of HLA-C Recognition by Killer Ig-like Receptor (KIR)2DL2 and KIR2DL3 and Restricted C1 Specificity of KIR2DS2: Dominant Impact of KIR2DL2/KIR2DS2 on KIR2D NK Cell Repertoire Formation
- (2013) G. David et al. JOURNAL OF IMMUNOLOGY
- New loci associated with chronic hepatitis B virus infection in Han Chinese
- (2013) Zhibin Hu et al. NATURE GENETICS
- Multi-Population Classical HLA Type Imputation
- (2013) Alexander Dilthey et al. PLoS Computational Biology
- IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B
- (2012) Pietro Lampertico et al. HEPATOLOGY
- Dissecting the divergent effects of interferon-alpha on immune cells: Time to rethink combination therapy in chronic hepatitis B?
- (2012) Robert Thimme et al. JOURNAL OF HEPATOLOGY
- Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
- (2012) Lorenzo Micco et al. JOURNAL OF HEPATOLOGY
- Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
- (2012) J.J. Ott et al. VACCINE
- HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
- (2011) Marie-Eve Blais et al. IMMUNOLOGY
- IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study
- (2011) Vijayaprakash Suppiah et al. PLOS MEDICINE
- Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-γ)
- (2010) W. E. AULITZKY et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels
- (2010) Vincent Rijckborst et al. HEPATOLOGY
- Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa
- (2009) Erik H.C.J. Buster et al. GASTROENTEROLOGY
- Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
- (2009) Patrick Marcellin et al. GASTROENTEROLOGY
- SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap
- (2008) A. D. Johnson et al. BIOINFORMATICS
- Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
- (2008) Rami Moucari et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started